Facial Plast Surg 2014; 30(02): 157-171
DOI: 10.1055/s-0034-1372423
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Potential of Topical and Injectable Growth Factors and Cytokines for Skin Rejuvenation

Sabrina Fabi
1   Goldman, Butterwick, Fitzpatrick, Groff & Fabi, Cosmetic Laser Dermatology, San Diego, California
2   Department of Dermatology, University of California, San Diego, California
,
Hema Sundaram
3   Sundaram Dermatology, Cosmetic & Laser Surgery, Rockville, Maryland
› Author Affiliations
Further Information

Publication History

Publication Date:
08 May 2014 (online)

Abstract

Growth factors and cytokines (referred to collectively hereafter as GFs) control cell growth, proliferation, and differentiation via a network of inter and intracellular signaling pathways. There are striking parallels between the pathways involved in skin wound healing and those implicated in photoaging of the skin. In recent years, topical and injectable GFs have emerged as an intriguing therapeutic modality that can be harnessed for aesthetic and medical purposes. This article provides a review of available evidence for the role in skin regeneration of topical GFs, and of injectable GFs contained in autologous platelet-rich plasma (PRP). It presents data from recent studies of GFs, offers a discussion of their potential to serve as antiaging actives, and includes safety considerations. As studies of injectable GFs typically assume preexisting familiarity with PRP protocols and the theory behind them, explanatory notes are provided. An assessment is provided of the evidence gaps that exist currently between experimental observations regarding GFs and their proven clinical benefits. Data of evidence levels II and III support the use for skin rejuvenation of topical GFs derived from sources including secretions or lysate of human dermal fibroblasts, and secretions of the snail Cryptomphalus aspersa. GFs with associated stem cell proteins, secreted by human dermal fibroblasts under hypoxic stress, can accelerate skin healing after laser resurfacing. In vitro and animal studies, small case series of PRP-treated patients and one prospective clinical study of its variant, platelet-rich fibrin matrix (PRFM), suggest the value of injectable GFs for skin rejuvenation. However, data of higher power are required to expand this proof of concept into an evidence-based paradigm. The clinical applications of topical and injectable GFs are promising, and remain to be fully defined. With continued study, data of higher evidence level can be accrued and formulations can be developed that offer optimal clinical efficacy, safety, tolerability, and stability. Better understanding of the mechanism of action of GFs can potentially advance our general understanding of dermal signaling pathways, and hence of hyaluronic acid and other alloplastic fillers; and allow the development of protocols for synergistic combination of GFs with other skin rejuvenation modalities.

 
  • References

  • 1 Schwartz E, Cruickshank FA, Christensen CC, Perlish JS, Lebwohl M. Collagen alterations in chronically sun-damaged human skin. Photochem Photobiol 1993; 58 (6) 841-844
  • 2 Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Am J Pathol 2004; 165 (3) 741-751
  • 3 Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107 (2) 135-142
  • 4 Martin P. Wound healing—aiming for perfect skin regeneration. Science 1997; 276 (5309) 75-81
  • 5 Hensley K, Floyd RA. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 2002; 397 (2) 377-383
  • 6 Babu M, Wells A. Dermal-epidermal communication in wound healing. Wounds 2001; 13(5): 183-189
  • 7 Fabi S, Sundaram H. Growth Factors in Cosmeceuticals. In: Farris P, , ed. Cosmeceuticals in Cosmetic Practice. New Jersey, NY: Wiley; 2014
  • 8 Sundaram H, Mehta RC, Norine JA , et al. Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenation. J Drugs Dermatol 2009; 8 (5, Suppl Skin Rejuvenation): 4-13
  • 9 Russell RP, Apostolakos J, Hirose T, Cote MP, Mazzocca AD. Variability of platelet-rich plasma preparations. Sports Med Arthrosc 2013; 21 (4) 186-190
  • 10 Rokhsar CK, Lee S, Fitzpatrick RE. Review of photorejuvenation: devices, cosmeceuticals, or both?. Dermatol Surg 2005; 31 (9, Pt 2) 1166-1178 , discussion 1178
  • 11 Varani J, Warner RL, Gharaee-Kermani M , et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 2000; 114 (3) 480-486
  • 12 El-Domyati M, Attia S, Saleh F , et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol 2002; 11 (5) 398-405
  • 13 Mori Y, Hatamochi A, Arakawa M, Ueki H. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts. Arch Dermatol Res 1998; 290 (3) 158-162
  • 14 Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007; 127 (3) 514-525
  • 15 Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995; 68 (1) 1-7
  • 16 Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Ther 2007; 20 (5) 350-359
  • 17 Cheng M, Wang H, Yoshida R, Murray MM. Platelets and plasma proteins are both required to stimulate collagen gene expression by anterior cruciate ligament cells in three-dimensional culture. Tissue Eng Part A 2010; 16 (5) 1479-1489
  • 18 Bonin-Debs AL, Boche I, Gille H, Brinkmann U. Development of secreted proteins as biotherapeutic agents. Expert Opin Biol Ther 2004; 4 (4) 551-558
  • 19 Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther 2003; 5 (1) 25-34
  • 20 Mehta RC, Smith SR, Grove GL , et al. Reduction in facial photodamage by a topical growth factor product. J Drugs Dermatol 2008; 7 (9) 864-871
  • 21 Hussain M, Phelps R, Goldberg DJ. Clinical, histologic, and ultrastructural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation. J Cosmet Laser Ther 2008; 10 (2) 104-109
  • 22 Fabi SG, Cohen JL, Peterson JD, Kiripolsky MG, Goldman MP. The effects of filtrate of the secretion of the Cryptomphalus aspersa on photoaged skin. J Drugs Dermatol 2013; 12 (4) 453-457
  • 23 Kellar RS, Hubka M, Rheins LA, Fisher G, Naughton GK. Hypoxic conditioned culture medium from fibroblasts grown under embryonic-like conditions supports healing following post-laser resurfacing. J Cosmet Dermatol 2009; 8 (3) 190-196
  • 24 Araki J, Jona M, Eto H , et al. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods 2012; 18 (3) 176-185
  • 25 Zimber MP, Mansbridge JN, Taylor M , et al. Human cell-conditioned media produced under embryonic-like conditions result in improved healing time after laser resurfacing. Aesthetic Plast Surg 2012; 36 (2) 431-437
  • 26 Cho HS, Song IH, Park SY, Sung MC, Ahn MW, Song KE. Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med 2011; 31 (3) 212-218
  • 27 Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 2011; 39 (2) 266-271
  • 28 Mazzocca AD, McCarthy MB, Chowaniec DM , et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012; 94 (4) 308-316
  • 29 Moojen DJ, Everts PA, Schure RM , et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008; 26 (3) 404-410
  • 30 Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27 (3) 158-167
  • 31 Han B, Woodell-May J, Ponticiello M, Yang Z, Nimni M. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am 2009; 91 (6) 1459-1470
  • 32 McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res 2009; 27 (8) 1033-1042
  • 33 Chamberlain CS, Leiferman EM, Frisch KE , et al. The influence of macrophage depletion on ligament healing. Connect Tissue Res 2011; 52 (3) 203-211
  • 34 Kawazoe T, Kim HH. Tissue augmentation by white blood cell-containing platelet-rich plasma. Cell Transplant 2012; 21 (2–3) 601-607
  • 35 Chang MY, Chan CK, Braun KR , et al. Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix. J Biol Chem 2012; 287 (17) 14122-14135
  • 36 Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med 2011; 39 (6) 1200-1208
  • 37 Miki A, Rivas-Carrillo JD, Navarro-Alvarez N , et al. Maintenance of neovascularization at the implantation site of an artificial device by bFGF and endothelial cell transplant. Cell Transplant 2006; 15(10): 893-901
  • 38 Ono I. The effects of basic fibroblast growth factor (bFGF) on the breaking strength of acute incisional wounds. J Dermatol Sci 2002; 29 (2) 104-113
  • 39 Spyrou GE, Naylor IL. The effect of basic fibroblast growth factor on scarring. Br J Plast Surg 2002; 55 (4) 275-282
  • 40 Yoshida R, Murray MM. Peripheral blood mononuclear cells enhance the anabolic effects of platelet-rich plasma on anterior cruciate ligament fibroblasts. J Orthop Res 2013; 31 (1) 29-34
  • 41 Naldini A, Morena E, Fimiani M, Campoccia G, Fossombroni V, Carraro F. The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells. Platelets 2008; 19 (4) 268-274
  • 42 Proffen BL, Haslauer CM, Harris CE, Murray MM. Mesenchymal stem cells from the retropatellar fat pad and peripheral blood stimulate ACL fibroblast migration, proliferation, and collagen gene expression. Connect Tissue Res 2013; 54 (1) 14-21
  • 43 Tsay RC, Vo J, Burke A, Eisig SB, Lu HH, Landesberg R. Differential growth factor retention by platelet-rich plasma composites. J Oral Maxillofac Surg 2005; 63 (4) 521-528
  • 44 Sclafani AP, Romo III T, Ukrainsky G , et al. Modulation of wound response and soft tissue ingrowth in synthetic and allogeneic implants with platelet concentrate. Arch Facial Plast Surg 2005; 7 (3) 163-169
  • 45 Hom DB, Linzie BM, Huang TC. The healing effects of autologous platelet gel on acute human skin wounds. Arch Facial Plast Surg 2007; 9 (3) 174-183
  • 46 Buckley A, Davidson JM, Kamerath CD, Wolt TB, Woodward SC. Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci U S A 1985; 82 (21) 7340-7344
  • 47 Anitua E, Sanchez M, Nurden AT , et al. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A 2006; 77 (2) 285-293
  • 48 Sclafani AP, Saman M. Platelet-rich fibrin matrix for facial plastic surgery. Facial Plast Surg Clin North Am 2012; 20 (2) 177-186 , vi
  • 49 Lundquist R, Dziegiel MH, Agren MS. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin. Wound Repair Regen 2008; 16 (3) 356-363
  • 50 Sclafani AP, McCormick SA. Induction of dermal collagenesis, angiogenesis, and adipogenesis in human skin by injection of platelet-rich fibrin matrix. Arch Facial Plast Surg 2012; 14 (2) 132-136
  • 51 Sclafani AP. Platelet-rich fibrin matrix for improvement of deep nasolabial folds. J Cosmet Dermatol 2010; 9 (1) 66-71
  • 52 Sclafani AP. Applications of platelet-rich fibrin matrix in facial plastic surgery. Facial Plast Surg 2009; 25 (4) 270-276
  • 53 Sclafani AP. Safety, efficacy, and utility of platelet-rich fibrin matrix in facial plastic surgery. Arch Facial Plast Surg 2011; 13 (4) 247-251
  • 54 Sundaram H, Carruthers J. Volumetric approach to the lower eyelid and midface. Clin Plast Surg 2014; ; in press
  • 55 Liu B, Earl HM, Baban D , et al. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophys Res Commun 1995; 217 (3) 721-727
  • 56 Zemtsov A, Montalvo-Lugo V. Topically applied growth factors change skin cytoplasmic creatine kinase activity and distribution and produce abnormal keratinocyte differentiation in murine skin. Skin Res Technol 2008; 14 (3) 370-375
  • 57 Graeven U, Fiedler W, Karpinski S , et al. Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR. J Cancer Res Clin Oncol 1999; 125 (11) 621-629
  • 58 Herold-Mende C, Steiner HH, Andl T , et al. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab Invest 1999; 79 (12) 1573-1582
  • 59 Fagien S, Cassuto D. Reconstituted injectable hyaluronic acid: expanded applications in facial aesthetics and additional thoughts on the mechanism of action in cosmetic medicine. Plast Reconstr Surg 2012; 130 (1) 208-217
  • 60 Paliwal S, Fagien S, Sun X , et al. Skin extracellular matrix (ECM) stimulation following injection of a hyaluronic acid-based dermal filler in a rat model. Poster presentation, American Society of Dermatologic Surgery 2013 Annual Meeting.